Know Labs, Inc., develops, markets, and sells proprietary technology solution for authenticating or diagnosing substances or materials. Its proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy along the electromagnetic spectrum to perform analytics, which allow the user to identify, authenticate, and diagnose materials and substances. The company, through its subsidiary TransTech Systems, Inc., distributes products for employee and personnel identification and authentication. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is based in Seattle, Washington.
Industry, Sector and Symbol
Industry Measuring & controlling devices, not elsewhere classified
Sub-IndustryN/A
SectorBusiness Services
CIKN/A
Phone206-903-1351
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$4.30 million
Profitability
Miscellaneous
Employees15
Next Earnings Date12/20/2019 (Estimated)
OptionableNot Optionable
Know Labs (OTCMKTS:KNWN) Frequently Asked Questions
What is Know Labs' stock symbol?
Know Labs trades on the OTCMKTS under the ticker symbol "KNWN."
How were Know Labs' earnings last quarter?
Know Labs Inc (OTCMKTS:KNWN) posted its quarterly earnings results on Wednesday, August, 7th. The company reported ($0.04) earnings per share for the quarter. The business had revenue of $0.38 million for the quarter. View Know Labs' Earnings History.
When is Know Labs' next earnings date?
Has Know Labs been receiving favorable news coverage?
News coverage about KNWN stock has trended somewhat positive this week, InfoTrie reports. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Know Labs earned a news sentiment score of 0.8 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Know Labs.
Who are some of Know Labs' key competitors?
What other stocks do shareholders of Know Labs own?
Who are Know Labs' key executives?
Know Labs' management team includes the folowing people:
- Mr. Ronald P. Erickson, Founder, Chairman, Interim CFO & Treasurer (Age 75)
- Mr. Phillip A. Bosua, CEO & Director (Age 45)
- Mr. Michael Grabham, Chief Bus. Officer (Age 56)
- Dr. James H. Anderson Jr., M.D., Chief Medical Officer and Chairman of Medical, Scientific & Regulatory Advisory Board
- Mr. Jeffrey Richard Kruse, Pres of TransTech Systems Inc (Age 61)
How do I buy shares of Know Labs?
Shares of KNWN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Know Labs' stock price today?
One share of KNWN stock can currently be purchased for approximately $1.29.
How big of a company is Know Labs?
What is Know Labs' official website?
How can I contact Know Labs?
Know Labs' mailing address is 500 UNION STREET SUITE 810, SEATTLE WA, 98101. The company can be reached via phone at 206-903-1351 or via email at [email protected]
MarketBeat Community Rating for Know Labs (OTCMKTS KNWN)
MarketBeat's community ratings are surveys of what our community members think about Know Labs and other stocks. Vote "Outperform" if you believe KNWN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KNWN will underperform the S&P 500 over the long term. You may vote once every thirty days.
